Raising money at 30¢ a share is ridiculous and incredibly dilutive if the company wants to raise enough money to fund the trial; remain in existence for at least another year; be taken seriously, and not deemed a pump and dump.
With the continued promise that Phase 1 trials will begin, I expect the R/S and then 1 or more capital raising rounds to follow.
We'll be alright if the phase 1 trial actually begins next quarter.
But gosh, they already pushed it back once by a quarter, and then a second time by a quarter.
It's my belief that management is in over their heads. They took on more than they understood.
If they get the trial started and have good results deeming a phase 2 trial, we'll be just fine.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM